JavaScript is disabled in your browser. Please enable JavaScript to view this website.

Serotonergic neuron markers

Your guide to selecting serotonergic neuron markers.

What are serotonergic neurons?

Serotonergic neurons, often referred to as serotonin neurons, are a specialized neuronal population that utilizes the neurotransmitter serotonin (5-HT) to communicate within the central nervous system. These neurons are predominantly located in the raphe nuclei of the brainstem, with the dorsal raphe nucleus serving as the largest and most significant source of central serotonergic neurons. Through their widespread projections, serotonergic neurons play a pivotal role in regulating a variety of brain functions, including mood, appetite, sleep, and cognitive function.

A key feature of serotonergic neurons is the presence of the serotonin transporter, a transmembrane protein responsible for the reuptake of serotonin from the synaptic cleft back into the presynaptic neuron. This process is essential for maintaining proper serotonergic signaling and is the primary target of selective serotonin reuptake inhibitors (SSRIs), a widely used class of antidepressants. By blocking the serotonin transporter, SSRIs increase serotonin levels in the synaptic cleft, providing therapeutic benefits for conditions such as major depressive disorder, obsessive-compulsive disorder, and bipolar disorder.

Recent advances in stem cell research have enabled the generation of serotonergic neurons from human pluripotent stem cells, including embryonic and induced pluripotent stem cells. These in vitro models allow researchers to study the molecular mechanisms underlying serotonergic neuron differentiation, maturation, and function. The use of genetically defined serotonin neurons has also facilitated the identification of specific serotonergic neuron markers, such as tryptophan hydroxylase, the rate-limiting enzyme involved in serotonin synthesis.

Serotonergic projections from the raphe nuclei, particularly the dorsal raphe, innervate multiple brain regions, including the prefrontal cortex, a region critical for higher-order cognitive functions like decision-making and impulse control. Disruptions in serotonergic signaling within the prefrontal cortex have been linked to various psychiatric disorders, highlighting the importance of this system in mental health. Innovative techniques such as optogenetic stimulation now allow researchers to selectively activate or inhibit serotonergic neurons in animal models, providing new insights into their role in behavior and cognitive processes.

In summary, serotonergic neurons are central to the regulation of diverse brain functions and are implicated in the pathophysiology of several psychiatric disorders. The development of stem cell-derived serotonergic neurons and identifying reliable serotonergic neuron markers have significantly advanced our understanding of their biology. Ongoing research into the molecular mechanisms and functional roles of serotonergic neurons holds promise for the development of more effective treatments for disorders involving serotonergic dysfunction.

Tryptophan hydroxylase (TPH2)

Tryptophan hydroxylase 2 (TPH2) is an enzyme found in serotonergic neurons, primarily within the brain’s raphe nuclei. It catalyzes the rate-limiting step in serotonin biosynthesis, converting tryptophan to 5-hydroxytryptophan. TPH2 is distinct from its peripheral counterpart, TPH1, and is widely used as a molecular marker to identify central serotonergic neurons. Its expression patterns help researchers study serotonin-related functions and disorders, including mood regulation and neuropsychiatric conditions. Genetic variations in TPH2 have been linked to altered serotonin levels and behavioral traits, making it a valuable focus in neuroscience and pharmacogenomics research

Immunohistochemistry (Frozen sections) - Anti-TPH2 antibody [EPR19191] (AB184505)

Figure 1. Immunohistochemistry (Frozen sections) - Anti-TPH2 antibody [EPR19191] (ab184505).

abID
Product name
Applications
Species
Clonality
Citations
ab184505
Anti-TPH2 antibody [EPR19191]
IP, WB, IHC-Fr, IHC-P
Mouse, rat
Monoclonal
26
ab211528
Anti-TPH2 antibody [CL2990] - C-terminal
IHC-P, IHC-P, IHC-P
Mouse, rat, human
Monoclonal
5

Browse all our TPH2 antibodies

View products
button-secondary
icon-right

Serotonin transporter (SERT)

The serotonin transporter (SERT), also known as SLC6A4, is a membrane protein that regulates serotonin levels in the brain by reabsorbing it from the synaptic cleft into presynaptic neurons. This reuptake process helps maintain serotonin balance and modulates neurotransmission. SERT is widely used as a molecular marker to identify serotonergic neurons due to its selective expression in these cells. It is also a key target for selective serotonin reuptake inhibitors (SSRIs), which influence mood and behavior. Studying SERT provides insights into serotonergic function and its role in psychiatric and neurological conditions.

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Serotonin transporter antibody [EPR23530-3] (AB254358)

Figure 2. Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Serotonin transporter antibody [EPR23530-3] (ab254358).

abID
Product name
Applications
Species
Clonality
Citations
ab254358
Anti-Serotonin transporter antibody [EPR23530-3]
IHC-P, IP, IHC-Fr
Mouse, rat
Monoclonal
1
ab130130
Anti-Serotonin transporter antibody
ICC
Human
Polyclonal
14

Browse all our SERT antibodies

View products
button-secondary
icon-right

Pet1

PET1, also known as FEV, is a transcription factor involved in the development and maintenance of serotonergic neurons. It plays a role in the specification of these neurons during embryogenesis and continues to influence their function into adulthood. PET1 regulates genes associated with serotonin synthesis, transport, and receptor expression, including TPH2 and SERT. Its expression is restricted mainly to serotonergic neurons, making it a reliable molecular marker for identifying this cell population. PET1 is also studied for its involvement in mood regulation and behavioral responses linked to serotonergic signaling.

Western blot - Anti-Pet1 antibody [HL2043] (AB308220)

Figure 3. Western blot - Anti-Pet1 antibody [HL2043] (ab308220).

abID
Product name
Applications
Species
Clonality
Citations
ab308220
Anti-Pet1 antibody [HL2043]
WB
Human
Monoclonal

Serotonin

Serotonin, or 5-hydroxytryptamine (5-HT), is a neurotransmitter synthesized and released by serotonergic neurons. It plays a role in regulating mood, sleep, appetite, and cognition. In neuroscience research, serotonin is used as a biochemical marker to identify serotonergic neurons due to its selective production and release by these cells. Techniques such as immunohistochemistry and in vitro assays help detect serotonin levels and distribution. Studying serotonin dynamics provides insights into brain function and disorders such as depression, anxiety, and autism spectrum conditions, where serotonergic signaling may be altered.

Immunohistochemistry (Frozen sections) - Anti-Serotonin antibody [YC5/45] (AB6336)

Figure 4. Immunohistochemistry (Frozen sections) - Anti-Serotonin antibody [YC5/45] (ab6336).

abID
Product name
Applications
Species
Clonality
Citations
ab6336
Anti-Serotonin antibody [YC5/45]
IHC-P, IHC-Fr
Monoclonal
26
ab66047
Anti-Serotonin antibody
IHC-FoFr
Polyclonal
87

Browse all our serotonin antibodies

View products
button-secondary
icon-right

References

  1. Deecher, D. C.  et al.  Desvenlafaxine succinate: a new serotonin and norepinephrine reuptake inhibitor.  J. Pharmacol. Exp. Ther.  318, 657–665 (2006).

  2. Hendricks, T. J.  et al.  Pet-1 ETS gene plays a role in 5-HT neuron development and is required for normal anxiety-like and aggressive behavior.  Neuron  37, 233–247 (2003).

  3. Kittler, K., Lau, T. & Schloss, P. Antagonists and substrates differentially regulate serotonin transporter cell surface expression in serotonergic neurons.  Eur. J. Pharmacol.  629, 63–67 (2010).

  4. Liu, C.  et al.  Pet-1 is required across different stages of life to regulate serotonergic function.  Nat. Neurosci.  13, 1190–1198 (2010).

  5. Zhou, J. Norepinephrine transporter inhibitors and their therapeutic potential.  Drugs Future  29, 1235–1244 (2004).